NovaBay Pharmaceuticals, Inc. revenue breakdown overview

NovaBay Pharmaceuticals, Inc. revenue for the last year amounted to 9.78 M USD, the most of which — 8.67 M USD — came from its highest performing source at the moment, Avenova Spray. The greatest contribution to the revenue figure was made by United States — last year it brought NovaBay Pharmaceuticals, Inc. 9.78 M USD, and the year before that — 14.73 M USD.